Total Payments
$11,208
2024 Payments
$3,843
Companies
60
Transactions
502
Medicare Patients
392
Medicare Billing
$31,080
Payment Breakdown by Category
Food & Beverage$9,978 (89.0%)
Education$1,230 (11.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,978 | 488 | 89.0% |
| Education | $1,230 | 14 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $1,535 | 36 | $0 (2023) |
| Janssen Biotech, Inc. | $773.74 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $688.92 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $673.13 | 41 | $0 (2024) |
| Eisai Inc. | $465.61 | 18 | $0 (2024) |
| Daiichi Sankyo Inc. | $447.08 | 19 | $0 (2024) |
| PFIZER INC. | $436.18 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $377.98 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $360.29 | 20 | $0 (2024) |
| Celgene Corporation | $358.99 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,843 | 184 | Janssen Biotech, Inc. ($372.99) |
| 2023 | $4,316 | 174 | Seagen Inc. ($1,112) |
| 2022 | $2,721 | 131 | Seagen Inc. ($403.92) |
| 2021 | $327.17 | 13 | GlaxoSmithKline, LLC. ($110.49) |
All Payment Transactions
502 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/23/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Hematology/Oncology | ||||||
| 12/18/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $23.65 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Oncology | ||||||
| 12/13/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $15.69 | General |
| 12/13/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $8.33 | General |
| 12/12/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Oncology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $3.99 | General |
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/21/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Oncology | ||||||
| 11/20/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| Category: Hematology/Oncology | ||||||
| 11/18/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 11/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.90 | General |
| 11/13/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 153 | 163 | $39,427 | $14,382 |
| 2022 | 2 | 27 | 27 | $4,880 | $1,193 |
| 2021 | 3 | 75 | 82 | $17,022 | $5,929 |
| 2020 | 3 | 137 | 157 | $29,133 | $9,576 |
Total Patients
392
Total Services
429
Medicare Billing
$31,080
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 60 | $13,380 | $4,893 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 39 | $11,661 | $4,459 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 47 | $7,144 | $2,733 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $7,242 | $2,297 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,636 | $779.24 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $2,244 | $413.28 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 29 | $6,351 | $2,292 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 34 | $5,066 | $2,032 | 40.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 19 | $5,605 | $1,604 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 86 | 100 | $14,748 | $5,049 | 34.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 40 | $8,690 | $2,836 | 32.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,695 | $1,691 | 29.7% |
About Michele Nobs, N.P
Michele Nobs, N.P is a Adult Health healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386619138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michele Nobs, N.P has received a total of $11,208 in payments from pharmaceutical and medical device companies, with $3,843 received in 2024. These payments were reported across 502 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($9,978).
As a Medicare-enrolled provider, Nobs has provided services to 392 Medicare beneficiaries, totaling 429 services with total Medicare billing of $31,080. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Saint Louis, MO
- Active Since 02/22/2006
- Last Updated 11/24/2014
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1386619138
Products in Payments
- KEYTRUDA (Biological) $688.92
- Lenvima (Drug) $465.61
- TUKYSA (Drug) $410.33
- OPDIVO (Biological) $305.51
- KISQALI (Drug) $304.23
- Enhertu (Drug) $261.54
- Nubeqa (Drug) $258.81
- REBLOZYL (Biological) $238.65
- DARZALEX (Biological) $235.10
- ERLEADA (Drug) $220.07
- LIBTAYO (Biological) $200.87
- IBRANCE (Drug) $167.81
- BAVENCIO (Drug) $158.71
- XPOVIO (Drug) $157.75
- MONJUVI (Drug) $153.41
- PADCEV (Biological) $149.98
- VENCLEXTA (Drug) $149.60
- VERZENIO (Drug) $148.19
- CABOMETYX (Drug) $144.22
- GILOTRIF (Drug) $142.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Saint Louis
Stephanie Vogel, Np-C, NP-C
Adult Health — Payments: $48,935
Adult Health $48,935
Jennifer Speiser, Np, NP
Adult Health — Payments: $14,376
Adult Health $14,376
Allyson Granden, Np-C, NP-C
Adult Health — Payments: $10,285
Adult Health $10,285
Marcee Stegemeier, Aprn-Bc, APRN-BC
Adult Health — Payments: $9,559
Adult Health $9,559
Heather Popham, Np, NP
Adult Health — Payments: $9,056
Adult Health $9,056
Joseph Lennartz, Agnp-C, AGNP-C
Adult Health — Payments: $8,257
Adult Health $8,257